A Phase 2 clinical trial testing the oral therapy GLPG3667 in people with systemic lupus erythematosus has failed to meet its ...
In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA).
Clinical Trials Arena on MSN
InnoCare’s BTK inhibitor advances to Phase III in SLE
During the Phase IIb study (NCT05688696), 187 patients with SLE were randomised to receive 48 weeks of treatment with either 75mg or 50mg orelabrutinib or placebo. Within the 48-week treatment window, ...
Perth’s St John of God Murdoch Hospital will carry out the study, which road tests Optiscan’s InVue and InForm devices. Based on confocal imaging, InVue enables surgeons to observe detailed, real-time ...
CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe cardiac abnormalities such as heart enlargement, valvulopathy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback